[Genquire-dev] Using these mailing lists as a CVS report?
Mark Wilkinson
mwilkinson@gene.pbi.nrc.ca
Thu, 17 Jan 2002 13:57:29 -0600
Hi again,
I find myself using these mailing lists (dev and user) as a report of bug
fixes. I am wondering if anyone objects to that? BioPerl has an automated
report of any code changes, which I quite like because I then know if I
should update my local copy... ours is not automated, but we are quite good
at using these lists to report code updates and changes.
I think this is good, but others may be annoyed at the amount of traffic on
this list. On the other hand, until we arrive at a final stable release
(only a couple of days away, I promise!), these changes are important to
both developers and users. Once the final release is out there I would
assume that we can drop most of the traffic on the -users list and restrict
the code change discussions to only the -dev list, since the developers
will presumably be the only ones using the cutting-edge code.
What do you all think about that?
Anyway, one more update to report. Matt Links uncovered a bug that may
have existed in ShowSequenceContext for a loooong time. It manifests
itself when changing feature boundaries of features on the '-' strand.
Although the display of the nucleotide sequence of the modified feature is
correct, the translation is not, and the underlying database feature itself
is not. I fixed that bug just before lunch and have committed the fix.
cvs update to get it.
M
--
--------------------------------
"Speed is subsittute fo accurancy."
________________________________
Dr. Mark Wilkinson
Bioinformatics Group
National Research Council of Canada
Plant Biotechnology Institute
110 Gymnasium Place
Saskatoon, SK
Canada